Propiedad y actividad de insiders de Quince Therapeutics, Inc. (QNCX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $27.17 |
| Capitalización | $8M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $7.3M | $24.9M | $51.2M | $66.8M | $69.7M | $44.6M | $20.8M | $6.2M | $5.8M |
| Inversiones a Corto | 0 | $46.8M | $48.6M | $67.0M | $37.1M | $45.6M | $54.3M | $34.6M | $11.9M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | $1.1M | 0 | $993000 | $882000 | $3.6M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $7.5M | $72.6M | $106.1M | $137.9M | $111.7M | $93.7M | $77.4M | $44.0M | $22.9M |
| Inmovilizado Material | $122000 | $283000 | $1.3M | $1.1M | $1.4M | $684000 | $619000 | $813000 | $1.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | $17.6M | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | $5.9M | $63.7M | $60.0M | $67.8M |
| Activos Totales | $7.7M | $72.9M | $124.4M | $189.5M | $133.2M | $103.9M | $180.2M | $114.5M | $93.5M |
| Cuentas por Pagar | $517000 | $495000 | $3.1M | $3.6M | $4.9M | $570000 | $2.0M | $2.9M | $2.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $64000 | 0 | $18.0M |
| Pasivos Corrientes | $1.8M | $1.5M | $8.9M | $17.0M | $14.2M | $3.1M | $9.6M | $7.3M | $43.2M |
| Deuda a Largo | $7.2M | 0 | 0 | 0 | 0 | 0 | $13.4M | $14.3M | $330000 |
| Pasivos Totales | $28.0M | $1.5M | $8.9M | $17.2M | $14.6M | $3.3M | $95.1M | $84.3M | $129.2M |
| Reservas | -$20.3M | -$32.8M | -$69.8M | -$146.7M | -$236.6M | -$288.3M | -$319.6M | -$376.5M | -$460.5M |
| Patrimonio Neto | -$20.3M | $71.4M | $115.5M | $172.3M | $118.6M | $100.6M | $85.1M | $30.1M | -$35.7M |
| Deuda Total | $7.2M | 0 | 0 | $446000 | $1.2M | $453000 | $13.8M | $14.8M | $18.5M |
| Deuda Neta | -$172000 | -$71.7M | -$99.9M | -$133.4M | -$105.6M | -$89.7M | -$61.2M | -$26.0M | $719000 |
| Capital Circulante | $5.8M | $71.1M | $97.2M | $120.9M | $97.5M | $90.7M | $67.9M | $36.8M | -$20.3M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 14.52 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -8.15 |
Rentabilidad
| Rentabilidad sobre capital | -413.28% |
| Rentabilidad sobre capital invertido | -104.64% |
| Rentabilidad sobre activos | -74.58% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ADVM · ALXO · ATYR · CAMP · CNTB · DTIL · GUTS
Explorar sector: Healthcare · Biotechnology
Más secciones de QNCX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones